cbdMD (YCBD) Income from Non-Controlling Interests (2018 - 2019)

cbdMD (YCBD) posted Income from Non-Controlling Interests of $712068.0 for Q3 2019, up 147.35% sequentially from -$1.5 million in Q2 2019.

cbdMD (YCBD) Income from Non-Controlling Interests (2018 - 2019) Analysis & Trends

cbdMD has reported Income from Non-Controlling Interests for 2 years, with the latest figure at $712068.0 in Q3 2019.

Quarterly Income from Non-Controlling Interests changed N/A year-over-year to $712068.0 in Q3 2019, while the trailing twelve-month figure through Jun 2020 was $712068.0 (changed N/A YoY) and the FY2019 annual result came in at -$929323.0, down 295.68% from the prior year.
Income from Non-Controlling Interests grew to $712068.0 in Q3 2019 per YCBD's latest filing, from -$1.5 million in the prior quarter.
Over five years, Income from Non-Controlling Interests peaked at $712068.0 in Q3 2019 and troughed at -$1.5 million in Q2 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Inc. Minority (Qtr)
1	Haleon	44.51 Bn	43.55 Bn	-	-
2	Teva Pharmaceutical Industries	43.52 Bn	39.86 Bn	2.15 Bn	-
3	Zoetis	32.43 Bn	30.75 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.63 Bn	22.83 Bn	5.10 Bn	376,434.15
5	United Therapeutics	21.87 Bn	19.21 Bn	683.80 Mn	-
6	Viatris	18.98 Bn	18.09 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.43 Bn	15.04 Bn	935.80 Mn	-
8	Elanco Animal Health	12.02 Bn	11.49 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.14 Bn	9.98 Bn	-	-
10	cbdMD	5.41 Mn	3.29 Mn	3.04 Mn	-

Download Data